上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1399Please respect copyright.PENANAZ3R6cvAmil
1399Please respect copyright.PENANAyaILRDqY9v
上集:https://www.penana.com/article/4711251399Please respect copyright.PENANA19lqzl1rim
1399Please respect copyright.PENANACNaxl6A1y31399Please respect copyright.PENANAPBnM60pllK
1399Please respect copyright.PENANAS0V93ZCED6
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1399Please respect copyright.PENANAWcAqaC5qOC
1399Please respect copyright.PENANACAH2jJksZV
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1399Please respect copyright.PENANA92iwBrVObz
1399Please respect copyright.PENANA76EJVBbMUq
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1399Please respect copyright.PENANAS7uo3Q0mXm
1399Please respect copyright.PENANAwZJwBiur3Y1399Please respect copyright.PENANAVR5Q3jtJgO
1399Please respect copyright.PENANABxnIdydRSr
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1399Please respect copyright.PENANAONpIwvzIH8
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1399Please respect copyright.PENANAqEdsssqNIH
1399Please respect copyright.PENANAiN2JG2OPJZ
忘記甚麼是Neoantigen的話,可重溫上一集。1399Please respect copyright.PENANAZrUb2d7ZSO
1399Please respect copyright.PENANAU4oZgd9Sfb
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1399Please respect copyright.PENANA7WFenI2zL0
1399Please respect copyright.PENANAcfwfKsIXdf
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1399Please respect copyright.PENANA8zzlRiHaR2
1399Please respect copyright.PENANAJ20Qwuh9r51399Please respect copyright.PENANAqCcnz4sbqE
1399Please respect copyright.PENANAnsvnY49QRu
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1399Please respect copyright.PENANARm5lu4p8tr
1399Please respect copyright.PENANAubce2Hgwix
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1399Please respect copyright.PENANAvtXuc5vUKP
1399Please respect copyright.PENANAZcAK7ZFysG
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1399Please respect copyright.PENANAb11KkEQ4va1399Please respect copyright.PENANAAYJhjLy2yZ
1399Please respect copyright.PENANAziUcSI7bqR
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1399Please respect copyright.PENANA6skMpU0PCi
1399Please respect copyright.PENANArS38hk3MhN
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1399Please respect copyright.PENANAFIQJ1obJJI1399Please respect copyright.PENANAwQGpN3OGtf
1399Please respect copyright.PENANAiFcpzselEz
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1399Please respect copyright.PENANAzuoWPLxQ5A
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1399Please respect copyright.PENANAry6DNouglN
1399Please respect copyright.PENANAQ8auRjMENd
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1399Please respect copyright.PENANAEcTvsXEqPX
1399Please respect copyright.PENANAyBSs0OhNwd
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1399Please respect copyright.PENANADXrOPZzJ8m
1399Please respect copyright.PENANAJ3B3tn4Xzk
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1399Please respect copyright.PENANAbYkKFycwoU
1399Please respect copyright.PENANASI5UamMsFG
1399Please respect copyright.PENANANQAEs6RkCH
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1399Please respect copyright.PENANA6tsA7geLOf
1399Please respect copyright.PENANABBCCR4IT7i
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1399Please respect copyright.PENANABSU7zSRKNn
1399Please respect copyright.PENANAEluDGXg5eK
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1399Please respect copyright.PENANA7flHzzebWX
1399Please respect copyright.PENANANqp17J6UPR
Link:1399Please respect copyright.PENANA4TQ5EK5a4S
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1399Please respect copyright.PENANAOyAFUbRbfe
1399Please respect copyright.PENANAxj2ghvUYsQ
1399Please respect copyright.PENANAnFMWPHzMBY
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1399Please respect copyright.PENANA5LMiEh4608